 | • レポートコード：MRC2-11QY01372 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は病院用注射薬のグローバル市場について調査・分析したレポートです。種類別（循環器・代謝障害、神経学、腫瘍学、自己免疫、消化器病学、血液学、痛み、感染症、その他）市場規模、用途別（病院薬局、小売薬局、Eコマース）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別病院用注射薬の競争状況、市場シェア ・世界の病院用注射薬市場：種類別市場規模 2015年-2020年（循環器・代謝障害、神経学、腫瘍学、自己免疫、消化器病学、血液学、痛み、感染症、その他） ・世界の病院用注射薬市場：種類別市場規模予測 2021年-2026年（循環器・代謝障害、神経学、腫瘍学、自己免疫、消化器病学、血液学、痛み、感染症、その他） ・世界の病院用注射薬市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、Eコマース） ・世界の病院用注射薬市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、Eコマース） ・北米の病院用注射薬市場分析：米国、カナダ ・ヨーロッパの病院用注射薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの病院用注射薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の病院用注射薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの病院用注射薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Baxter International Inc.、Sanofi、Pfizer Inc.、GlaxoSmithKline plc、AstraZeneca、Gilead、Sciences、Merck & Co.、Novartis AG、Johnson & Johnson、Novo Nordisk A/S ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Drug injection is a method of introducing a drug into the bloodstream via a hollow hypodermic needle and a syringe, which is pierced through the skin into the body.
Injectable drugs bypasses first-pass metabolism in the liver, resulting in higher bioavailability and efficiency for many drugs (such as morphine or diacetylmorphine/heroin; roughly two-thirds of which is destroyed in the liver when consumed orally) than oral ingestion would, meaning users get a stronger (yet shorter-acting) effect from the same amount of the drug.
Market Analysis and Insights: Global Hospital Injectable Drugs Market
The global Hospital Injectable Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Hospital Injectable Drugs Scope and Market Size
Hospital Injectable Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hospital Injectable Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Hospital Injectable Drugs market is segmented into
Cardiology& Metabolicdisorders
Neurology
Oncology
Autoimmune
Gastroenterology
Hematology
Pain
Infectiousdiseases
Others
Segment by Application, the Hospital Injectable Drugs market is segmented into
HospitalPharmacy
RetailPharmacy
E-commerce
Regional and Country-level Analysis
The Hospital Injectable Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Hospital Injectable Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Hospital Injectable Drugs Market Share Analysis
Hospital Injectable Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Hospital Injectable Drugs business, the date to enter into the Hospital Injectable Drugs market, Hospital Injectable Drugs product introduction, recent developments, etc.
The major vendors covered:
Baxter International Inc.
Sanofi
Pfizer Inc.
GlaxoSmithKline plc
AstraZeneca
Gilead
Sciences
Merck & Co.
Novartis AG
Johnson & Johnson
Novo Nordisk A/S
1 Study Coverage
1.1 Hospital Injectable Drugs Product Introduction
1.2 Market Segments
1.3 Key Hospital Injectable Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Hospital Injectable Drugs Market Size Growth Rate by Type
1.4.2 Cardiology& Metabolicdisorders
1.4.3 Neurology
1.4.4 Oncology
1.4.5 Autoimmune
1.4.6 Gastroenterology
1.4.7 Hematology
1.4.8 Pain
1.4.9 Infectiousdiseases
1.4.10 Others
1.5 Market by Application
1.5.1 Global Hospital Injectable Drugs Market Size Growth Rate by Application
1.5.2 HospitalPharmacy
1.5.3 RetailPharmacy
1.5.4 E-commerce
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Hospital Injectable Drugs Market Size, Estimates and Forecasts
2.1.1 Global Hospital Injectable Drugs Revenue 2015-2026
2.1.2 Global Hospital Injectable Drugs Sales 2015-2026
2.2 Global Hospital Injectable Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Hospital Injectable Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Hospital Injectable Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Hospital Injectable Drugs Competitor Landscape by Players
3.1 Hospital Injectable Drugs Sales by Manufacturers
3.1.1 Hospital Injectable Drugs Sales by Manufacturers (2015-2020)
3.1.2 Hospital Injectable Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Hospital Injectable Drugs Revenue by Manufacturers
3.2.1 Hospital Injectable Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Hospital Injectable Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Hospital Injectable Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Hospital Injectable Drugs Revenue in 2019
3.2.5 Global Hospital Injectable Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Hospital Injectable Drugs Price by Manufacturers
3.4 Hospital Injectable Drugs Manufacturing Base Distribution, Product Types
3.4.1 Hospital Injectable Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hospital Injectable Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Hospital Injectable Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Hospital Injectable Drugs Market Size by Type (2015-2020)
4.1.1 Global Hospital Injectable Drugs Sales by Type (2015-2020)
4.1.2 Global Hospital Injectable Drugs Revenue by Type (2015-2020)
4.1.3 Hospital Injectable Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Hospital Injectable Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Hospital Injectable Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Hospital Injectable Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Hospital Injectable Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Hospital Injectable Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Hospital Injectable Drugs Market Size by Application (2015-2020)
5.1.1 Global Hospital Injectable Drugs Sales by Application (2015-2020)
5.1.2 Global Hospital Injectable Drugs Revenue by Application (2015-2020)
5.1.3 Hospital Injectable Drugs Price by Application (2015-2020)
5.2 Hospital Injectable Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Hospital Injectable Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Hospital Injectable Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Hospital Injectable Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Hospital Injectable Drugs by Country
6.1.1 North America Hospital Injectable Drugs Sales by Country
6.1.2 North America Hospital Injectable Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Hospital Injectable Drugs Market Facts & Figures by Type
6.3 North America Hospital Injectable Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Hospital Injectable Drugs by Country
7.1.1 Europe Hospital Injectable Drugs Sales by Country
7.1.2 Europe Hospital Injectable Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Hospital Injectable Drugs Market Facts & Figures by Type
7.3 Europe Hospital Injectable Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Hospital Injectable Drugs by Region
8.1.1 Asia Pacific Hospital Injectable Drugs Sales by Region
8.1.2 Asia Pacific Hospital Injectable Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Hospital Injectable Drugs Market Facts & Figures by Type
8.3 Asia Pacific Hospital Injectable Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Hospital Injectable Drugs by Country
9.1.1 Latin America Hospital Injectable Drugs Sales by Country
9.1.2 Latin America Hospital Injectable Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Hospital Injectable Drugs Market Facts & Figures by Type
9.3 Central & South America Hospital Injectable Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Hospital Injectable Drugs by Country
10.1.1 Middle East and Africa Hospital Injectable Drugs Sales by Country
10.1.2 Middle East and Africa Hospital Injectable Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Hospital Injectable Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Hospital Injectable Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Baxter International Inc.
11.1.1 Baxter International Inc. Corporation Information
11.1.2 Baxter International Inc. Description and Business Overview
11.1.3 Baxter International Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Baxter International Inc. Hospital Injectable Drugs Products Offered
11.1.5 Baxter International Inc. Related Developments
11.2 Sanofi
11.2.1 Sanofi Corporation Information
11.2.2 Sanofi Description and Business Overview
11.2.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Sanofi Hospital Injectable Drugs Products Offered
11.2.5 Sanofi Related Developments
11.3 Pfizer Inc.
11.3.1 Pfizer Inc. Corporation Information
11.3.2 Pfizer Inc. Description and Business Overview
11.3.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Pfizer Inc. Hospital Injectable Drugs Products Offered
11.3.5 Pfizer Inc. Related Developments
11.4 GlaxoSmithKline plc
11.4.1 GlaxoSmithKline plc Corporation Information
11.4.2 GlaxoSmithKline plc Description and Business Overview
11.4.3 GlaxoSmithKline plc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 GlaxoSmithKline plc Hospital Injectable Drugs Products Offered
11.4.5 GlaxoSmithKline plc Related Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Corporation Information
11.5.2 AstraZeneca Description and Business Overview
11.5.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.5.4 AstraZeneca Hospital Injectable Drugs Products Offered
11.5.5 AstraZeneca Related Developments
11.6 Gilead
11.6.1 Gilead Corporation Information
11.6.2 Gilead Description and Business Overview
11.6.3 Gilead Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Gilead Hospital Injectable Drugs Products Offered
11.6.5 Gilead Related Developments
11.7 Sciences
11.7.1 Sciences Corporation Information
11.7.2 Sciences Description and Business Overview
11.7.3 Sciences Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Sciences Hospital Injectable Drugs Products Offered
11.7.5 Sciences Related Developments
11.8 Merck & Co.
11.8.1 Merck & Co. Corporation Information
11.8.2 Merck & Co. Description and Business Overview
11.8.3 Merck & Co. Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Merck & Co. Hospital Injectable Drugs Products Offered
11.8.5 Merck & Co. Related Developments
11.9 Novartis AG
11.9.1 Novartis AG Corporation Information
11.9.2 Novartis AG Description and Business Overview
11.9.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Novartis AG Hospital Injectable Drugs Products Offered
11.9.5 Novartis AG Related Developments
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Corporation Information
11.10.2 Johnson & Johnson Description and Business Overview
11.10.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Johnson & Johnson Hospital Injectable Drugs Products Offered
11.10.5 Johnson & Johnson Related Developments
11.1 Baxter International Inc.
11.1.1 Baxter International Inc. Corporation Information
11.1.2 Baxter International Inc. Description and Business Overview
11.1.3 Baxter International Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Baxter International Inc. Hospital Injectable Drugs Products Offered
11.1.5 Baxter International Inc. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Hospital Injectable Drugs Market Estimates and Projections by Region
12.1.1 Global Hospital Injectable Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Hospital Injectable Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Hospital Injectable Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Hospital Injectable Drugs Sales Forecast (2021-2026)
12.2.2 North America: Hospital Injectable Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Hospital Injectable Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Hospital Injectable Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Hospital Injectable Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Hospital Injectable Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Hospital Injectable Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Hospital Injectable Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Hospital Injectable Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Hospital Injectable Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Hospital Injectable Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Hospital Injectable Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Hospital Injectable Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Hospital Injectable Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Hospital Injectable Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Hospital Injectable Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Hospital Injectable Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Hospital Injectable Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Hospital Injectable Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Hospital Injectable Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hospital Injectable Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Hospital Injectable Drugs Market Segments
Table 2. Ranking of Global Top Hospital Injectable Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Hospital Injectable Drugs Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of Cardiology& Metabolicdisorders
Table 5. Major Manufacturers of Neurology
Table 6. Major Manufacturers of Oncology
Table 7. Major Manufacturers of Autoimmune
Table 8. Major Manufacturers of Gastroenterology
Table 9. Major Manufacturers of Hematology
Table 10. Major Manufacturers of Pain
Table 11. Major Manufacturers of Infectiousdiseases
Table 12. Major Manufacturers of Others
Table 13. Global Hospital Injectable Drugs Market Size Growth Rate by Application 2020-2026 (MT)
Table 14. Global Hospital Injectable Drugs Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 15. Global Hospital Injectable Drugs Sales by Regions 2015-2020 (MT)
Table 16. Global Hospital Injectable Drugs Sales Market Share by Regions (2015-2020)
Table 17. Global Hospital Injectable Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Hospital Injectable Drugs Sales by Manufacturers (2015-2020) (MT)
Table 19. Global Hospital Injectable Drugs Sales Share by Manufacturers (2015-2020)
Table 20. Global Hospital Injectable Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Hospital Injectable Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hospital Injectable Drugs as of 2019)
Table 22. Hospital Injectable Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Hospital Injectable Drugs Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Hospital Injectable Drugs Price (2015-2020) (USD/Kg)
Table 25. Hospital Injectable Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Hospital Injectable Drugs Product Type
Table 27. Date of International Manufacturers Enter into Hospital Injectable Drugs Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Hospital Injectable Drugs Sales by Type (2015-2020) (MT)
Table 30. Global Hospital Injectable Drugs Sales Share by Type (2015-2020)
Table 31. Global Hospital Injectable Drugs Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Hospital Injectable Drugs Revenue Share by Type (2015-2020)
Table 33. Hospital Injectable Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Kg)
Table 34. Global Hospital Injectable Drugs Sales by Application (2015-2020) (MT)
Table 35. Global Hospital Injectable Drugs Sales Share by Application (2015-2020)
Table 36. North America Hospital Injectable Drugs Sales by Country (2015-2020) (MT)
Table 37. North America Hospital Injectable Drugs Sales Market Share by Country (2015-2020)
Table 38. North America Hospital Injectable Drugs Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Hospital Injectable Drugs Revenue Market Share by Country (2015-2020)
Table 40. North America Hospital Injectable Drugs Sales by Type (2015-2020) (MT)
Table 41. North America Hospital Injectable Drugs Sales Market Share by Type (2015-2020)
Table 42. North America Hospital Injectable Drugs Sales by Application (2015-2020) (MT)
Table 43. North America Hospital Injectable Drugs Sales Market Share by Application (2015-2020)
Table 44. Europe Hospital Injectable Drugs Sales by Country (2015-2020) (MT)
Table 45. Europe Hospital Injectable Drugs Sales Market Share by Country (2015-2020)
Table 46. Europe Hospital Injectable Drugs Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Hospital Injectable Drugs Revenue Market Share by Country (2015-2020)
Table 48. Europe Hospital Injectable Drugs Sales by Type (2015-2020) (MT)
Table 49. Europe Hospital Injectable Drugs Sales Market Share by Type (2015-2020)
Table 50. Europe Hospital Injectable Drugs Sales by Application (2015-2020) (MT)
Table 51. Europe Hospital Injectable Drugs Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Hospital Injectable Drugs Sales by Region (2015-2020) (MT)
Table 53. Asia Pacific Hospital Injectable Drugs Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Hospital Injectable Drugs Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Hospital Injectable Drugs Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Hospital Injectable Drugs Sales by Type (2015-2020) (MT)
Table 57. Asia Pacific Hospital Injectable Drugs Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Hospital Injectable Drugs Sales by Application (2015-2020) (MT)
Table 59. Asia Pacific Hospital Injectable Drugs Sales Market Share by Application (2015-2020)
Table 60. Latin America Hospital Injectable Drugs Sales by Country (2015-2020) (MT)
Table 61. Latin America Hospital Injectable Drugs Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Hospital Injectable Drugs Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Hospital Injectable Drugs Revenue Market Share by Country (2015-2020)
Table 64. Latin America Hospital Injectable Drugs Sales by Type (2015-2020) (MT)
Table 65. Latin America Hospital Injectable Drugs Sales Market Share by Type (2015-2020)
Table 66. Latin America Hospital Injectable Drugs Sales by Application (2015-2020) (MT)
Table 67. Latin America Hospital Injectable Drugs Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Hospital Injectable Drugs Sales by Country (2015-2020) (MT)
Table 69. Middle East and Africa Hospital Injectable Drugs Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Hospital Injectable Drugs Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Hospital Injectable Drugs Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Hospital Injectable Drugs Sales by Type (2015-2020) (MT)
Table 73. Middle East and Africa Hospital Injectable Drugs Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Hospital Injectable Drugs Sales by Application (2015-2020) (MT)
Table 75. Middle East and Africa Hospital Injectable Drugs Sales Market Share by Application (2015-2020)
Table 76. Baxter International Inc. Corporation Information
Table 77. Baxter International Inc. Description and Major Businesses
Table 78. Baxter International Inc. Hospital Injectable Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 79. Baxter International Inc. Product
Table 80. Baxter International Inc. Recent Development
Table 81. Sanofi Corporation Information
Table 82. Sanofi Description and Major Businesses
Table 83. Sanofi Hospital Injectable Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 84. Sanofi Product
Table 85. Sanofi Recent Development
Table 86. Pfizer Inc. Corporation Information
Table 87. Pfizer Inc. Description and Major Businesses
Table 88. Pfizer Inc. Hospital Injectable Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 89. Pfizer Inc. Product
Table 90. Pfizer Inc. Recent Development
Table 91. GlaxoSmithKline plc Corporation Information
Table 92. GlaxoSmithKline plc Description and Major Businesses
Table 93. GlaxoSmithKline plc Hospital Injectable Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 94. GlaxoSmithKline plc Product
Table 95. GlaxoSmithKline plc Recent Development
Table 96. AstraZeneca Corporation Information
Table 97. AstraZeneca Description and Major Businesses
Table 98. AstraZeneca Hospital Injectable Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 99. AstraZeneca Product
Table 100. AstraZeneca Recent Development
Table 101. Gilead Corporation Information
Table 102. Gilead Description and Major Businesses
Table 103. Gilead Hospital Injectable Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 104. Gilead Product
Table 105. Gilead Recent Development
Table 106. Sciences Corporation Information
Table 107. Sciences Description and Major Businesses
Table 108. Sciences Hospital Injectable Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 109. Sciences Product
Table 110. Sciences Recent Development
Table 111. Merck & Co. Corporation Information
Table 112. Merck & Co. Description and Major Businesses
Table 113. Merck & Co. Hospital Injectable Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 114. Merck & Co. Product
Table 115. Merck & Co. Recent Development
Table 116. Novartis AG Corporation Information
Table 117. Novartis AG Description and Major Businesses
Table 118. Novartis AG Hospital Injectable Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 119. Novartis AG Product
Table 120. Novartis AG Recent Development
Table 121. Johnson & Johnson Corporation Information
Table 122. Johnson & Johnson Description and Major Businesses
Table 123. Johnson & Johnson Hospital Injectable Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 124. Johnson & Johnson Product
Table 125. Johnson & Johnson Recent Development
Table 126. Novo Nordisk A/S Corporation Information
Table 127. Novo Nordisk A/S Description and Major Businesses
Table 128. Novo Nordisk A/S Hospital Injectable Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 129. Novo Nordisk A/S Product
Table 130. Novo Nordisk A/S Recent Development
Table 131. Global Hospital Injectable Drugs Sales Forecast by Regions (2021-2026) (MT)
Table 132. Global Hospital Injectable Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 133. Global Hospital Injectable Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 134. Global Hospital Injectable Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 135. North America: Hospital Injectable Drugs Sales Forecast by Country (2021-2026) (MT)
Table 136. North America: Hospital Injectable Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Europe: Hospital Injectable Drugs Sales Forecast by Country (2021-2026) (MT)
Table 138. Europe: Hospital Injectable Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Asia Pacific: Hospital Injectable Drugs Sales Forecast by Region (2021-2026) (MT)
Table 140. Asia Pacific: Hospital Injectable Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 141. Latin America: Hospital Injectable Drugs Sales Forecast by Country (2021-2026) (MT)
Table 142. Latin America: Hospital Injectable Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Middle East and Africa: Hospital Injectable Drugs Sales Forecast by Country (2021-2026) (MT)
Table 144. Middle East and Africa: Hospital Injectable Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 145. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 146. Key Challenges
Table 147. Market Risks
Table 148. Main Points Interviewed from Key Hospital Injectable Drugs Players
Table 149. Hospital Injectable Drugs Customers List
Table 150. Hospital Injectable Drugs Distributors List
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Hospital Injectable Drugs Product Picture
Figure 2. Global Hospital Injectable Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Cardiology& Metabolicdisorders Product Picture
Figure 4. Neurology Product Picture
Figure 5. Oncology Product Picture
Figure 6. Autoimmune Product Picture
Figure 7. Gastroenterology Product Picture
Figure 8. Hematology Product Picture
Figure 9. Pain Product Picture
Figure 10. Infectiousdiseases Product Picture
Figure 11. Others Product Picture
Figure 12. Global Hospital Injectable Drugs Sales Market Share by Application in 2020 & 2026
Figure 13. HospitalPharmacy
Figure 14. RetailPharmacy
Figure 15. E-commerce
Figure 16. Hospital Injectable Drugs Report Years Considered
Figure 17. Global Hospital Injectable Drugs Market Size 2015-2026 (US$ Million)
Figure 18. Global Hospital Injectable Drugs Sales 2015-2026 (MT)
Figure 19. Global Hospital Injectable Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 20. Global Hospital Injectable Drugs Sales Market Share by Region (2015-2020)
Figure 21. Global Hospital Injectable Drugs Sales Market Share by Region in 2019
Figure 22. Global Hospital Injectable Drugs Revenue Market Share by Region (2015-2020)
Figure 23. Global Hospital Injectable Drugs Revenue Market Share by Region in 2019
Figure 24. Global Hospital Injectable Drugs Sales Share by Manufacturer in 2019
Figure 25. The Top 10 and 5 Players Market Share by Hospital Injectable Drugs Revenue in 2019
Figure 26. Hospital Injectable Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Hospital Injectable Drugs Sales Market Share by Type (2015-2020)
Figure 28. Global Hospital Injectable Drugs Sales Market Share by Type in 2019
Figure 29. Global Hospital Injectable Drugs Revenue Market Share by Type (2015-2020)
Figure 30. Global Hospital Injectable Drugs Revenue Market Share by Type in 2019
Figure 31. Global Hospital Injectable Drugs Market Share by Price Range (2015-2020)
Figure 32. Global Hospital Injectable Drugs Sales Market Share by Application (2015-2020)
Figure 33. Global Hospital Injectable Drugs Sales Market Share by Application in 2019
Figure 34. Global Hospital Injectable Drugs Revenue Market Share by Application (2015-2020)
Figure 35. Global Hospital Injectable Drugs Revenue Market Share by Application in 2019
Figure 36. North America Hospital Injectable Drugs Sales Growth Rate 2015-2020 (MT)
Figure 37. North America Hospital Injectable Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 38. North America Hospital Injectable Drugs Sales Market Share by Country in 2019
Figure 39. North America Hospital Injectable Drugs Revenue Market Share by Country in 2019
Figure 40. U.S. Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)
Figure 41. U.S. Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Canada Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)
Figure 43. Canada Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. North America Hospital Injectable Drugs Market Share by Type in 2019
Figure 45. North America Hospital Injectable Drugs Market Share by Application in 2019
Figure 46. Europe Hospital Injectable Drugs Sales Growth Rate 2015-2020 (MT)
Figure 47. Europe Hospital Injectable Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 48. Europe Hospital Injectable Drugs Sales Market Share by Country in 2019
Figure 49. Europe Hospital Injectable Drugs Revenue Market Share by Country in 2019
Figure 50. Germany Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)
Figure 51. Germany Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. France Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)
Figure 53. France Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. U.K. Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)
Figure 55. U.K. Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Italy Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)
Figure 57. Italy Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Russia Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)
Figure 59. Russia Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Europe Hospital Injectable Drugs Market Share by Type in 2019
Figure 61. Europe Hospital Injectable Drugs Market Share by Application in 2019
Figure 62. Asia Pacific Hospital Injectable Drugs Sales Growth Rate 2015-2020 (MT)
Figure 63. Asia Pacific Hospital Injectable Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 64. Asia Pacific Hospital Injectable Drugs Sales Market Share by Region in 2019
Figure 65. Asia Pacific Hospital Injectable Drugs Revenue Market Share by Region in 2019
Figure 66. China Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)
Figure 67. China Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Japan Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)
Figure 69. Japan Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. South Korea Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)
Figure 71. South Korea Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. India Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)
Figure 73. India Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Australia Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)
Figure 75. Australia Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Taiwan Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)
Figure 77. Taiwan Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Indonesia Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)
Figure 79. Indonesia Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Thailand Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)
Figure 81. Thailand Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Malaysia Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)
Figure 83. Malaysia Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Philippines Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)
Figure 85. Philippines Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Vietnam Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)
Figure 87. Vietnam Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Asia Pacific Hospital Injectable Drugs Market Share by Type in 2019
Figure 89. Asia Pacific Hospital Injectable Drugs Market Share by Application in 2019
Figure 90. Latin America Hospital Injectable Drugs Sales Growth Rate 2015-2020 (MT)
Figure 91. Latin America Hospital Injectable Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 92. Latin America Hospital Injectable Drugs Sales Market Share by Country in 2019
Figure 93. Latin America Hospital Injectable Drugs Revenue Market Share by Country in 2019
Figure 94. Mexico Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)
Figure 95. Mexico Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Brazil Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)
Figure 97. Brazil Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Argentina Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)
Figure 99. Argentina Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Latin America Hospital Injectable Drugs Market Share by Type in 2019
Figure 101. Latin America Hospital Injectable Drugs Market Share by Application in 2019
Figure 102. Middle East and Africa Hospital Injectable Drugs Sales Growth Rate 2015-2020 (MT)
Figure 103. Middle East and Africa Hospital Injectable Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 104. Middle East and Africa Hospital Injectable Drugs Sales Market Share by Country in 2019
Figure 105. Middle East and Africa Hospital Injectable Drugs Revenue Market Share by Country in 2019
Figure 106. Turkey Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)
Figure 107. Turkey Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Saudi Arabia Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)
Figure 109. Saudi Arabia Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. U.A.E Hospital Injectable Drugs Sales Growth Rate (2015-2020) (MT)
Figure 111. U.A.E Hospital Injectable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 112. Middle East and Africa Hospital Injectable Drugs Market Share by Type in 2019
Figure 113. Middle East and Africa Hospital Injectable Drugs Market Share by Application in 2019
Figure 114. North America Hospital Injectable Drugs Sales Growth Rate Forecast (2021-2026) (MT)
Figure 115. North America Hospital Injectable Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Europe Hospital Injectable Drugs Sales Growth Rate Forecast (2021-2026) (MT)
Figure 117. Europe Hospital Injectable Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Asia Pacific Hospital Injectable Drugs Sales Growth Rate Forecast (2021-2026) (MT)
Figure 119. Asia Pacific Hospital Injectable Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Latin America Hospital Injectable Drugs Sales Growth Rate Forecast (2021-2026) (MT)
Figure 121. Latin America Hospital Injectable Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Middle East and Africa Hospital Injectable Drugs Sales Growth Rate Forecast (2021-2026) (MT)
Figure 123. Middle East and Africa Hospital Injectable Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Porter's Five Forces Analysis
Figure 125. Channels of Distribution
Figure 126. Distributors Profiles
Figure 127. Bottom-up and Top-down Approaches for This Report
Figure 128. Data Triangulation
Figure 129. Key Executives Interviewed
注射薬の世界市場（～2026年） Drug injection is a method of introducing a drug into the bloodstream via a hollow hypodermic needle and a syringe, which is pierced through the skin into the body. Injectable drugs bypasses first-pass metabolism in the liver, resulting in higher bioavailability and efficiency for many drugs (such a…- 無菌注射薬の世界市場（～2026年） Sterile injectable drugs are sterile, parenteral preparations containing one more Active Pharmaceutical Ingredient (API) intended for administration into the body. Growth of the global sterile injectable drugs is primarily driven by increasing demand for novel drug delivery systems, rising prevalenc…
- 特殊注射用ジェネリック医薬品の世界市場（～2026年） Market Analysis and Insights: Global Specialty Injectable Generics Market The global Specialty Injectable Generics market size is projected to reach US$ 10240 million by 2026, from US$ 9378.7 million in 2020, at a CAGR of 8.4%% during 2021-2026. Global Specialty Injectable Generics Scope and Market …
- 注射可能型ドラッグデリバリーの世界市場（～2026年） Injectable drug delivery is defined as introduction of a drug or drugs in the patient by using a delivery device. Injectables allow the transport of drugs formulated in liquid form, directly in the body. Even though, they may be designed to transport the drug to specific part of the body. North Amer…
- 長時間作用型注射剤（LAI）の世界市場（～2026年） Long-acting injectables (LAIs) are unique tools used in psychiatric pharmacy to help improve patient outcomes. They offer a number of benefits compared to oral therapy, including confirmed patient adherence, consistent drug delivery, predictable bioavailability and prevention of antipsychotic overdo…